Cargando…

P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA

Detalles Bibliográficos
Autores principales: Yu, Wenyan, Geng, Mei, Hao, Jie, Yan, Zeying, MI, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431191/
http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4
_version_ 1785091142991216640
author Yu, Wenyan
Geng, Mei
Hao, Jie
Yan, Zeying
MI, Jian-Qing
author_facet Yu, Wenyan
Geng, Mei
Hao, Jie
Yan, Zeying
MI, Jian-Qing
author_sort Yu, Wenyan
collection PubMed
description
format Online
Article
Text
id pubmed-10431191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311912023-08-17 P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA Yu, Wenyan Geng, Mei Hao, Jie Yan, Zeying MI, Jian-Qing Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431191/ http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Yu, Wenyan
Geng, Mei
Hao, Jie
Yan, Zeying
MI, Jian-Qing
P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_full P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_fullStr P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_full_unstemmed P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_short P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_sort p1074: prognosis analysis and a new risk model for relapsed and refractory hodgkin lymphoma patients treated by anti-pd-1: a real-world multicenter retrospective study of patients in china
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431191/
http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4
work_keys_str_mv AT yuwenyan p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT gengmei p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT haojie p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT yanzeying p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT mijianqing p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina